Trials / Completed
CompletedNCT00696774
Switching to Duloxetine in Patients With Depression
Attributes of Response in Depressed Patients Switched to Treatment With Duloxetine (ARDENT Study)
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 242 (actual)
- Sponsor
- Eli Lilly and Company · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to help answer the following research question: Whether switching to duloxetine improves depressed mood when current treatment did not work well for patients with depression.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Duloxetine | Study Period II (Acute Therapy): 60 mg capsules, QD, for 4 weeks. Study Period III (Optimization): Responder group - 60 mg capsules, QD, for 4 weeks more. Non-responder group - 120 mg capsules, QD, for 4 weeks more. |
Timeline
- Start date
- 2008-06-01
- Primary completion
- 2009-07-01
- Completion
- 2009-07-01
- First posted
- 2008-06-13
- Last updated
- 2010-09-08
- Results posted
- 2010-08-11
Locations
2 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT00696774. Inclusion in this directory is not an endorsement.